← Back to Search

Family History App for Cancer Prevention (FHAMe Trial)

N/A
Waitlist Available
Led By June Carroll, MD
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
30-69 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

FHAMe Trial Summary

This trial is testing a new way to record family history information that includes an app to improve use by family physicians and patients. The goal is to reduce cancer deaths and chronic disease burden.

Who is the study for?
This trial is for individuals aged 30-69 who are patients of staff physicians with an email registered in the OCEAN system. It's not suitable for pregnant individuals or those under the care of resident physicians.Check my eligibility
What is being tested?
The trial is testing a new app-based approach to recording family health history (FHAMe Intervention) to improve its use by family doctors and patients, aiming to enhance decision-making and increase appropriate referrals for high-risk conditions.See study design
What are the potential side effects?
Since this intervention involves using an app and improving communication rather than medication, there are no direct medical side effects. However, participants may experience increased anxiety or concern from learning about their potential genetic risks.

FHAMe Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 30 and 69 years old.

FHAMe Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in risk-appropriate screening based on family history
Family history of breast/ovarian/colorectal/prostate cancer
Positive family history documentation
+3 more
Secondary outcome measures
Attitudes towards the FHAMe intervention
Participation rate
Recruitment rate
+1 more

FHAMe Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
In addition to usual care, patients will be asked to answer questions about any family history through the use of a questionnaire.
Group II: Usual CareActive Control1 Intervention
Patients receive usual care, which consists of health care providers inquiring about and dealing with family history as they would in usual practice.

Find a Location

Who is running the clinical trial?

University of TorontoLead Sponsor
688 Previous Clinical Trials
1,017,923 Total Patients Enrolled
8 Trials studying Breast Cancer
2,645 Patients Enrolled for Breast Cancer
June Carroll, MDPrincipal InvestigatorMOUNT SINAI HOSPITAL

Media Library

FHAMe Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04726319 — N/A
Breast Cancer Research Study Groups: Intervention, Usual Care
Breast Cancer Clinical Trial 2023: FHAMe Intervention Highlights & Side Effects. Trial Name: NCT04726319 — N/A
FHAMe Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04726319 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is geriatric participation allowed in this research study?

"This medical trial is only open to patients between the ages of 30 and 69. In contrast, there are 301 trials for those under 18 years old and 6984 studies for individuals above 65."

Answered by AI

What results does this research endeavor intend to manifest?

"The central metric of this investigation, measured over a one-year period, is the ratio of participants between arms that document family history in their electronic medical record. Secondary objectives include gauging patient and team responses to the FHAMe intervention through questionnaires and interviews; analyzing recruitment rate during the experiment's duration; and examining how patients' family histories were procured and applied by clinicians with surveys and dialogues."

Answered by AI

Does this research endeavor accept new enrollees?

"According to clinicaltrials.gov, this trial is not presently open for recruitment; it was initially posted on September 20th 2021 and the last update occurred on August 10th 2022. On the other hand, there are numerous trials that actively require patients - 7239 at present - which can be found on the website."

Answered by AI

Am I eligible to join the clinical trial research?

"This medical trial requires 627 prostate cancer patients aged between 30 and 69 to enroll. Eligibility criteria also mandates that applicants fall within this age bracket."

Answered by AI
~179 spots leftby Apr 2025